Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan Seeks Regulation Of Imported Chinese Medicines

This article was originally published in PharmAsia News

Executive Summary

A series of Taiwan and Chinese trade discussions are expected to take up Taiwan's desire to regulate traditional Chinese medicines as part of a group of issues the two countries are considering. Taiwan's Department of Health minister told a legislative committee the government hopes to use a selection of the Chinese medicines for priority consultations. An estimated 90 percent of Chinese medicines Taiwanese import are made in China and 80 percent of those are usually directly by consumers. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067606

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel